Financial Statement Restatements (Details Textual)	12 Months Ended
Feb. 28, 2019
Financial Statement Restatements (Textual)
Description of financial statement restatement and amended amounts	i. Accounts payable and selling, general & administration expense were understated by $31,395, respectively, with respect to unrecorded expense related to outside consultant and legal expense incurred during fiscal year 2019. ii. Additional paid-in capital and selling, general & administration expense were overstated by $1,991,740, respectively, due to an incorrect fair value associated with common shares issued during 2019 to BetterSea, a technical consultant to the Company (see Note 8). iii. Accounts payable was overstated and gain on debt settlement was understated by $100,000, respectively, with respect to amounts incorrectly recorded as an accounts payable due to a vendor. iv. Restated basic and diluted loss per share for the year ended February 28, 2019 reduced by $0.05 due to the reduced restated net loss for the same period and the restated weighted average number of common shares outstanding for the same period increased by 272,428 shares. The balance sheet at February 28, 2019 was restated for common shares outstanding from 52,082,083 to 53,714,145. v. Notes payable, general & administration expense, gain on debt settlement and additional paid-in capital are amended to include $80,162 in accrued legal expense and recognition of a net loss of $26,212 related to the issuance of 111,092 common shares in connection with the September 2019 Agreement Regarding Payment of Court Judgment in Installments, On Timeline, And Staying Execution ("Abdou Payment Agreement"), in which the Company was held liable for payment of such expense (see note 14) over a period ending November 15, 2020. In addition to the legal expenses of $80,162, the Company is reclassifying the principle amount of $125,000 from convertible notes payable and $110,000 of accrued interest reported previously as part of accrued expenses to note payable on the balance sheet as of February 28, 2019, including that portion due within twelve months from February 28, 2019 of $70,000 as part of notes payable, current portion. vi. Additional paid-in capital was understated by and accrued expense was overstated by $67,893 as a result of cash payments received by the Company prior to February 28, 2019 for a definitive number of common shares and recorded as a liability.

Financial Statement Restatements (Details Textual)

12 Months Ended

Feb. 28, 2019

Financial Statement Restatements (Textual)

Description of financial statement restatement and amended amounts

i. Accounts payable and selling, general & administration expense were understated by $31,395, respectively, with respect to unrecorded expense related to outside consultant and legal expense incurred during fiscal year 2019. ii. Additional paid-in capital and selling, general & administration expense were overstated by $1,991,740, respectively, due to an incorrect fair value associated with common shares issued during 2019 to BetterSea, a technical consultant to the Company (see Note 8). iii. Accounts payable was overstated and gain on debt settlement was understated by $100,000, respectively, with respect to amounts incorrectly recorded as an accounts payable due to a vendor. iv. Restated basic and diluted loss per share for the year ended February 28, 2019 reduced by $0.05 due to the reduced restated net loss for the same period and the restated weighted average number of common shares outstanding for the same period increased by 272,428 shares. The balance sheet at February 28, 2019 was restated for common shares outstanding from 52,082,083 to 53,714,145. v. Notes payable, general & administration expense, gain on debt settlement and additional paid-in capital are amended to include $80,162 in accrued legal expense and recognition of a net loss of $26,212 related to the issuance of 111,092 common shares in connection with the September 2019 Agreement Regarding Payment of Court Judgment in Installments, On Timeline, And Staying Execution ("Abdou Payment Agreement"), in which the Company was held liable for payment of such expense (see note 14) over a period ending November 15, 2020. In addition to the legal expenses of $80,162, the Company is reclassifying the principle amount of $125,000 from convertible notes payable and $110,000 of accrued interest reported previously as part of accrued expenses to note payable on the balance sheet as of February 28, 2019, including that portion due within twelve months from February 28, 2019 of $70,000 as part of notes payable, current portion. vi. Additional paid-in capital was understated by and accrued expense was overstated by $67,893 as a result of cash payments received by the Company prior to February 28, 2019 for a definitive number of common shares and recorded as a liability.